Skip to content
  • About
  • Contact
  • Contribute
  • Book
  • Careers
  • Podcast
  • Recommended
  • Speaking
  • All
  • Physician
  • Practice
  • Policy
  • Finance
  • Conditions
  • .edu
  • Patient
  • Meds
  • Tech
  • Social
  • Video
    • All
    • Physician
    • Practice
    • Policy
    • Finance
    • Conditions
    • .edu
    • Patient
    • Meds
    • Tech
    • Social
    • Video
    • About
    • Contact
    • Contribute
    • Book
    • Careers
    • Podcast
    • Recommended
    • Speaking

The effects of the nationwide stimulant shortage on a private psychiatry practice

Christine Tran-Boynes, DO
Meds
February 8, 2023
75 Shares
Share
Tweet
Share

I have a solo outpatient private practice focusing on psychiatric medication management and brief therapy for adults. Early on, I decided to accept insurance to help address the shortage of psychiatrists in this country. Because of the advances in telemedicine since the pandemic, I can see patients throughout the state where I am licensed. This should be the happiest time in my career. After several years of working as an employee for several hospitals, I can now practice medicine on my own terms. Given the abundance of out-of-network psychiatrists in my area, patients are often grateful to be seen despite the wait for an initial appointment.

However, one situation has been stressful for my patients and me: the current nationwide stimulant shortage.

Stimulants, such as Adderall, Ritalin, and Concerta, are first-line treatments for ADHD. Often considered a childhood condition, ADHD can persist into adulthood, especially with inattentive symptoms. Although not found in the DSM-5-TR criteria for ADHD, studies have shown that those with ADHD have a higher rate of debt.

Additionally, stimulants can be used to treat depression and narcolepsy.

Due to their risk of misuse, stimulants are classified as Schedule II controlled substances by the DEA. Before the declaration of a public health emergency due to COVID in January 2020, a federal law called the Ryan Haight Act mandated that an in-person medical evaluation be conducted before a controlled substance can be prescribed. However, with the public health emergency, the Ryan Haight Act has been waived, and the public health emergency was recently renewed for another 90 days on January 11, 2023.

On October 12, 2022, the FDA announced the nationwide shortage of Adderall. As psychiatrists were substituting other stimulants for Adderall, shortages of other stimulants soon followed, including Ritalin.

There are several reasons for the stimulant shortage. One, Teva, one of the largest manufacturers of Adderall, was experiencing production delays due to a worker shortage in October 2022. Additionally, the DEA imposes an annual maximum production of stimulants to avoid misuse. Lastly, there has been an increase in demand for stimulants, especially with the waiver of the Ryan Haight Act during the public health emergency and the subsequent ability to prescribe stimulants during telemedicine visits.

Sadly, the stimulant shortage is expected to last well into 2023.

How is the stimulant shortage affecting the patients in my practice? Some patients have resorted to taking their medications only on the weekdays, when they need them the most for work or school. Others call their pharmacy and are put on hold for as long as an hour, only to be told that information about stimulant supplies cannot be provided over the phone. A few have had success visiting several pharmacies in person. A couple of determined patients have traveled three hours to fill their prescriptions.

As an adult psychiatrist, I treat ADHD less frequently than my child and adolescent psychiatrist colleagues. As a result, I am less familiar with the newer, brand-name stimulants on the market. However, with the shortage, I find myself using these exact brand-name stimulants with the guidance of colleagues as well as reviewing continuing medical education material that address conversions of different stimulants. With this, I am spending more administrative time completing prior authorizations and obtaining manufacturer coupons from pharmaceutical companies. Once, I spent 90 minutes in a peer-to-peer review with an insurance company.

In the media, the opioid crisis has been at the forefront. However, I believe there is also a stimulant crisis occurring right now. There is a feeling of helplessness when I cannot provide the medications I prescribe for my patients. Although I am frustrated, it probably does not compare to how my patients are feeling. That said, the stimulant shortage has only added to the moral injury of psychiatrists throughout the country.

Christine Tran-Boynes is a psychiatrist.

Prev

The hidden toll of racism in medicine: a doctor's perspective

February 8, 2023 Kevin 0
…
Next

Navigating the gray area: a doctor's perspective on treating a colleague

February 8, 2023 Kevin 1
…

Tagged as: Psychiatry

Post navigation

< Previous Post
The hidden toll of racism in medicine: a doctor's perspective
Next Post >
Navigating the gray area: a doctor's perspective on treating a colleague

More by Christine Tran-Boynes, DO

  • 5 ways to manage anxiety during the coronavirus pandemic

    Christine Tran-Boynes, DO

Related Posts

  • Why the baby formula shortage happened

    Divya Srinivasan and Tejas Sekhar
  • International medical graduates ease the U.S. doctor shortage

    G. Richard Olds, MD
  • How to start reversing the clinician shortage today

    Timothy Lee, MPH
  • Medical school is more than practice problems

    Kira Kopacz
  • Why a prison psychiatry rotation should be mandatory for all medical students

    Tiana Walker
  • A shortage of Kayexalate leads to an ER visit

    Hans Duvefelt, MD

More in Meds

  • Telemedicine in the opioid crisis: a game-changer threatened by DEA regulations

    Julie Craig, MD
  • The real cause of America’s opioid crisis: Doctors are not to blame

    Richard A. Lawhern, PhD
  • Can personalized medicine live up to its hype in health care?

    Ketan Desai, MD, PhD
  • Why North American medical cannabis can’t compete globally

    Michael Sassano
  • How were we duped and what can we do about the opioid overdose crisis?

    Ronald A. Zent, MD
  • Caught in the middle: How health insurance companies influence cancer drug selection

    Paul Pender, MD
  • Most Popular

  • Past Week

    • It’s time for C-suite to contract directly with physicians for part-time work

      Aaron Morgenstein, MD & Corinne Sundar Rao, MD | Physician
    • What is driving physicians to the edge of despair?

      Edward T. Creagan, MD | Physician
    • The untold struggles patients face with resident doctors

      Denise Reich | Conditions
    • The psychoanalytic hammer: lessons in listening and patient-centered care

      Greg Smith, MD | Conditions
    • Physicians are a finite resource we need to protect

      Jack Resneck, Jr., MD | Physician
    • Revolutionizing COPD management with virtual care solutions [PODCAST]

      The Podcast by KevinMD | Podcast
  • Past 6 Months

    • The real cause of America’s opioid crisis: Doctors are not to blame

      Richard A. Lawhern, PhD | Meds
    • The fight for reproductive health: Why medication abortion matters

      Catherine Hennessey, MD | Physician
    • The vital importance of climate change education in medical schools

      Helen Kim, MD | Policy
    • Nobody wants this job. Should physicians stick around?

      Katie Klingberg, MD | Physician
    • It’s time for C-suite to contract directly with physicians for part-time work

      Aaron Morgenstein, MD & Corinne Sundar Rao, MD | Physician
    • Resetting the doctor-patient relationship: Navigating the challenges of modern primary care

      Jeffrey H. Millstein, MD | Physician
  • Recent Posts

    • Physicians are a finite resource we need to protect

      Jack Resneck, Jr., MD | Physician
    • From clocking in to clocking out: the transition to retirement

      Debbie Moore-Black, RN | Conditions
    • Breaking free from a toxic relationship with medicine [PODCAST]

      The Podcast by KevinMD | Podcast
    • Tom Brady’s legacy and the importance of personal integrity in end-of-life choices

      Kevin Haselhorst, MD | Physician
    • The hidden truths of hospital life: What doctors wish you knew

      Emily Stanford, DO | Physician
    • 10 commandments of ethical affiliate marketing for physicians

      Aaron Morgenstein, MD & Amy Bissada, DO | Finance

Subscribe to KevinMD and never miss a story!

Get free updates delivered free to your inbox.


Find jobs at
Careers by KevinMD.com

Search thousands of physician, PA, NP, and CRNA jobs now.

Learn more

Leave a Comment

Founded in 2004 by Kevin Pho, MD, KevinMD.com is the web’s leading platform where physicians, advanced practitioners, nurses, medical students, and patients share their insight and tell their stories.

Social

  • Like on Facebook
  • Follow on Twitter
  • Connect on Linkedin
  • Subscribe on Youtube
  • Instagram

CME Spotlights

From MedPage Today

Latest News

  • Journal Shows Its Commitment to Exploring AI in Medicine
  • Do Away With 'Lockout' Period in iPLEDGE, FDA Advisors Urge
  • Cluster Headache, Migraine Linked to Circadian System
  • Smaller Liver Transplant Candidates Wait Longer, Less Likely to Receive Organ
  • A 'Double Whammy' for Gastric Cancer Risk

Meeting Coverage

  • Oral Roflumilast Effective in the Treatment of Plaque Psoriasis
  • Phase III Trials 'Hit a Home Run' in Advanced Endometrial Cancer
  • Cannabis Use Common in Post-Surgery Patients on Opioid Tapering
  • Less Abuse With Extended-Release Oxycodone, Poison Center Data Suggest
  • Novel Strategies Show Winning Potential in Ovarian Cancer
  • Most Popular

  • Past Week

    • It’s time for C-suite to contract directly with physicians for part-time work

      Aaron Morgenstein, MD & Corinne Sundar Rao, MD | Physician
    • What is driving physicians to the edge of despair?

      Edward T. Creagan, MD | Physician
    • The untold struggles patients face with resident doctors

      Denise Reich | Conditions
    • The psychoanalytic hammer: lessons in listening and patient-centered care

      Greg Smith, MD | Conditions
    • Physicians are a finite resource we need to protect

      Jack Resneck, Jr., MD | Physician
    • Revolutionizing COPD management with virtual care solutions [PODCAST]

      The Podcast by KevinMD | Podcast
  • Past 6 Months

    • The real cause of America’s opioid crisis: Doctors are not to blame

      Richard A. Lawhern, PhD | Meds
    • The fight for reproductive health: Why medication abortion matters

      Catherine Hennessey, MD | Physician
    • The vital importance of climate change education in medical schools

      Helen Kim, MD | Policy
    • Nobody wants this job. Should physicians stick around?

      Katie Klingberg, MD | Physician
    • It’s time for C-suite to contract directly with physicians for part-time work

      Aaron Morgenstein, MD & Corinne Sundar Rao, MD | Physician
    • Resetting the doctor-patient relationship: Navigating the challenges of modern primary care

      Jeffrey H. Millstein, MD | Physician
  • Recent Posts

    • Physicians are a finite resource we need to protect

      Jack Resneck, Jr., MD | Physician
    • From clocking in to clocking out: the transition to retirement

      Debbie Moore-Black, RN | Conditions
    • Breaking free from a toxic relationship with medicine [PODCAST]

      The Podcast by KevinMD | Podcast
    • Tom Brady’s legacy and the importance of personal integrity in end-of-life choices

      Kevin Haselhorst, MD | Physician
    • The hidden truths of hospital life: What doctors wish you knew

      Emily Stanford, DO | Physician
    • 10 commandments of ethical affiliate marketing for physicians

      Aaron Morgenstein, MD & Amy Bissada, DO | Finance

MedPage Today Professional

An Everyday Health Property Medpage Today iMedicalApps
  • Terms of Use | Disclaimer
  • Privacy Policy
  • DMCA Policy
All Content © KevinMD, LLC
Site by Outthink Group

Leave a Comment

Comments are moderated before they are published. Please read the comment policy.

Loading Comments...